Recruiting NA INTERVENTIONAL 1-arm NCT07181590

BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF (BLAST-OFF)

Sponsor: Abbott Medical Devices

Conditions Atrial Arrhythmia Atrial Fibrillation Paroxysmal AF Persistent Atrial Fibrillation

Updated 3 times since 2025 Last updated: Mar 2, 2026 Started: Dec 11, 2025 Primary completion: Aug 31, 2027 Completion: Aug 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Atrial Arrhythmia and Atrial Fibrillation, this trial is actively recruiting participants. The trial is conducted by Abbott Medical Devices and has accumulated 3 data snapshots since 2025. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

3 versions recorded

Mar 2026 — Present [monthly]

Recruiting NA
Feb 2026 — Mar 2026 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Oct 2025 — Feb 2026 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Medical Devices

Data source: Abbott Medical Devices

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Ancona, Italy , Bad Oeynhausen, Germany , Bruges, Belgium , Brussels, Belgium , Cologne, Germany , Copenhagen, Denmark , Dublin, Ireland , Groningen, Netherlands , Hamburg, Germany and 12 more locations